IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses

Journal of Autoimmunity

Volumn 50, Issue , 2014, Pages 12-22

  Chong, Wai Po ^a   Horai, Reiko ^a   Mattapallil, Mary J ^a   Silver, Phyllis B ^a   Chen, Jun ^a   Zhou, Ru ^a   Sergeev, Yuri ^a   Villasmil, Rafael ^a   Chan, Chi Chao ^a   Caspi, Rachel R ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Autoimmunity; Gp130; IL 27p28

Indexed keywords

IL27 PROTEIN, MOUSE; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE; TRANSCRIPTION FACTOR;

ANIMAL; AUTOIMMUNITY; CELL LINEAGE; CELL MOTION; CENTRAL NERVOUS SYSTEM; DRUG EFFECTS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TRANSGENIC MOUSE; UVEITIS;

ANIMALS; AUTOIMMUNITY; CELL LINEAGE; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; INTERLEUKINS; MICE; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; TH1 CELLS; TH17 CELLS; TRANSCRIPTION FACTORS; UVEITIS;

EID: 84899106289     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.08.003     Document Type: Article

References (60)

1. Caspi R.R. Alook at autoimmunity and inflammation in the eye. JClin Invest 2010, 120:3073-3083.
2. Ooi K.G., Galatowicz G., Calder V.L., Lightman S.L. Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?. Clin Med Res 2006, 4:294-309.
3. Chi W., Yang P., Li B., Wu C., Jin H., Zhu X., et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. JAllergy Clin Immunol 2007, 119:1218-1224.
4. Amadi-Obi A., Yu C.R., Liu X., Mahdi R.M., Clarke G.L., Nussenblatt R.B., et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007, 13:711-718.
5. Axtell R.C., Raman C., Steinman L. Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity. Clin Rev Allergy Immunol 2012.
6. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. JExp Med 2008, 205:799-810.
7. Tang J., Zhu W., Silver P.B., Su S.B., Chan C.C., Caspi R.R. Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. JImmunol 2007, 178:5578-5587.
8. Yi T., Zhao D., Lin C.L., Zhang C., Chen Y., Todorov I., et al. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 2008, 112:2101-2110.
9. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. JImmunol 2006, 177:566-573.
10. Kastelein R.A., Hunter C.A., Cua D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007, 25:221-242.
11. Chen Z., O'Shea J.J. Th17 cells: a new fate for differentiating helper T cells. Immunol Res 2008, 41:87-102.
12. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T.W., et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. JImmunol 2003, 170:4886-4890.
13. Owaki T., Asakawa M., Fukai F., Mizuguchi J., Yoshimoto T. IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways. JImmunol 2006, 177:7579-7587.
14. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997, 15:797-819.
15. Hohki S., Ohguro N., Haruta H., Nakai K., Terabe F., Serada S., et al. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Exp Eye Res 2010, 91:162-170.
16. Sonoda K.H., Yoshimura T., Takeda A., Ishibashi T., Hamano S., Yoshida H. WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis. Int Immunol 2007, 19:93-98.
17. Novartis Third quarter results, investor presentation October 21, 2010 2010, http://wwwnovartiscom/newsroom/media-releases/en/2010/1453762shtml.
18. Hueber W., Sands B.E., Lewitzky S., Vandemeulebroecke M., Reinisch W., Higgins P.D., et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 2012.
19. Stumhofer J.S., Tait E.D., Quinn W.J., Hosken N., Spudy B., Goenka R., et al. Arole for IL-27p28 as an antagonist of gp130-mediated signaling. Nat Immunol 2010, 11:1119-1126.
20. Pepperberg D.R., Okajima T.L., Ripps H., Chader G.J., Wiggert B. Functional properties of interphotoreceptor retinoid-binding protein. Photochem Photobiol 1991, 54:1057-1060.
21. Agarwal R.K., Caspi R.R. Rodent models of experimental autoimmune uveitis. Methods Mol Med 2004, 102:395-419.
22. Silver P.B., Agarwal R.K., Su S.B., Suffia I., Grajewski R.S., Luger D., et al. Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells. JImmunol 2007, 179:5146-5158.
23. Apetoh L., Quintana F.J., Pot C., Joller N., Xiao S., Kumar D., et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol 2010, 11:854-861.
24. Needleman S.B., Wunsch C.D. Ageneral method applicable to the search for similarities in the amino acid sequence of two proteins. JMol Biol 1970, 48:443-453.
25. Lee C., Subbiah S. Prediction of protein side-chain conformation by packing optimization. JMol Biol 1991, 217:373-388.
26. Levitt M. Accurate modeling of protein conformation by automatic segment matching. JMol Biol 1992, 226:507-533.
27. Codarri L., Gyulveszi G., Tosevski V., Hesske L., Fontana A., Magnenat L., et al. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 2011, 12:560-567.
28. El-Behi M., Ciric B., Dai H., Yan Y., Cullimore M., Safavi F., et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 2011, 12:568-575.
29. Muraguchi A., Kishimoto T., Miki Y., Kuritani T., Kaieda T., Yoshizaki K., et al. Tcell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. JImmunol 1981, 127:412-416.
30. Muraguchi A., Hirano T., Tang B., Matsuda T., Horii Y., Nakajima K., et al. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. JExp Med 1988, 167:332-344.
31. Senaldi G., Varnum B.C., Sarmiento U., Starnes C., Lile J., Scully S., et al. Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc Natl Acad Sci U S A 1999, 96:11458-11463.
32. Larousserie F., Charlot P., Bardel E., Froger J., Kastelein R.A., Devergne O. Differential effects of IL-27 on human B cell subsets. JImmunol 2006, 176:5890-5897.
33. Caspi R.R., Roberge F.G., McAllister C.G., el-Saied M., Kuwabara T., Gery I., et al. Tcell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. JImmunol 1986, 136:928-933.
34. Pennesi G., Mattapallil M.J., Sun S.H., Avichezer D., Silver P.B., Karabekian Z., et al. Ahumanized model of experimental autoimmune uveitis in HLA class II transgenic mice. JClin Invest 2003, 111:1171-1180.
35. Wojno E.D., Hosken N., Stumhofer J.S., O'Hara A.C., Mauldin E., Fang Q., et al. Arole for IL-27 in limiting T regulatory cell populations. JImmunol 2011, 187:266-273.
36. Cox J.H., Kljavin N.M., Ramamoorthi N., Diehl L., Batten M., Ghilardi N. IL-27 promotes T cell-dependent colitis through multiple mechanisms. JExp Med 2011, 208:115-123.
37. Lucas S., Ghilardi N., Li J., de Sauvage F.J. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 2003, 100:15047-15052.
38. Caspi R.R. Understanding autoimmune uveitis through animal models. The Friedenwald Lecture. Invest Ophthalmol Vis Sci 2010, 52:1872-1879.
39. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
40. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002, 16:779-790.
41. Yoshida H., Hamano S., Senaldi G., Covey T., Faggioni R., Mu S., et al. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001, 15:569-578.
42. McGeachy M.J., Chen Y., Tato C.M., Laurence A., Joyce-Shaikh B., Blumenschein W.M., et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells invivo. Nat Immunol 2009, 10:314-324.
43. Horai R., Caspi R.R. Cytokines in autoimmune uveitis. JInterferon Cytokine Res 2011, 31:733-744.
44. Kebir H., Ifergan I., Alvarez J.I., Bernard M., Poirier J., Arbour N., et al. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann Neurol 2009, 66:390-402.
45. Eid R.E., Rao D.A., Zhou J., Lo S.F., Ranjbaran H., Gallo A., et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009, 119:1424-1432.
46. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). JImmunol 1996, 156:5-7.
47. Krakowski M., Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 1996, 26:1641-1646.
48. Jones L.S., Rizzo L.V., Agarwal R.K., Tarrant T.K., Chan C.C., Wiggert B., et al. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. JImmunol 1997, 158:5997-6005.
49. Hofstetter H.H., Ibrahim S.M., Koczan D., Kruse N., Weishaupt A., Toyka K.V., et al. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 2005, 237:123-130.
50. Haak S., Croxford A.L., Kreymborg K., Heppner F.L., Pouly S., Becher B., et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. JClin Invest 2009, 119:61-69.
51. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. JExp Med 2005, 201:233-240.
52. Samoilova E.B., Horton J.L., Hilliard B., Liu T.S., Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. JImmunol 1998, 161:6480-6486.
53. Ghoreschi K., Laurence A., Yang X.P., Tato C.M., McGeachy M.J., Konkel J.E., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010, 467:967-971.
54. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006, 7:929-936.
55. Fitzgerald D.C., Zhang G.X., El-Behi M., Fonseca-Kelly Z., Li H., Yu S., et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 2007, 8:1372-1379.
56. Freitas do Rosario A.P., Lamb T., Spence P., Stephens R., Lang A., Roers A., et al. IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. JImmunol 2012, 188:1178-1190.
57. Wang R.X., Yu C.R., Mahdi R.M., Egwuagu C.E. Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis (EAU) by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells. JBiol Chem 2012.
58. Garbers C., Spudy B., Aparicio-Siegmund S., Waetzig G.H., Sommer J., Holscher C., et al. An Interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer. JBiol Chem 2013, 288:4346-4354.
59. Juttler E., Tarabin V., Schwaninger M. Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity. Neuroscientist: A Rev J Bringing Neurobiol Neurol Psychiatry 2002, 8:268-275.
60. Horai R., Silver P.B., Chen J., Agarwal R.K., Chong W.P., Jittayasothorn Y., et al. Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen. J Autoimmun 2013, 44:21-33.